Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 429-433

  Groselj, Blaz ^a   Kerr, Martin ^a   Kiltie, Anne E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bladder cancer; Histone deacetylase inhibitor; Ku80; Panobinostat; Radiosensitisation

Indexed keywords

HISTONE GAMMA H2AX; HISTONE H2AX; KU80 PROTEIN; MEMBRANE PROTEIN; PANOBINOSTAT; RAD51 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CHEMOSENSITIVITY; CLONOGENIC ASSAY; CONFOCAL MICROSCOPY; DNA END JOINING REPAIR; FLUORESCENCE ACTIVATED CELL SORTING; G2 PHASE CELL CYCLE CHECKPOINT; HOMOLOGOUS RECOMBINATION; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IONIZING RADIATION; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RADIOSENSITIZATION; WESTERN BLOTTING;

BLADDER CANCER; HISTONE DEACETYLASE INHIBITOR; KU80; PANOBINOSTAT; RADIOSENSITISATION;

ANTIGENS, NUCLEAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HISTONES; HUMANS; HYDROXAMIC ACIDS; INDOLES; RAD51 RECOMBINASE; RADIATION-SENSITIZING AGENTS; URINARY BLADDER NEOPLASMS;

EID: 84887018542     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.021     Document Type: Article

References (26)

1. A. Stenzl, N.C. Cowan, and M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
2. S. Kotwal, A. Choudhury, C. Johnston, A.B. Paul, P. Whelan, and A.E. Kiltie Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center Int J Radiat Oncol Biol Phys 70 2008 456 463
3. C. Wang, and S.P. Lees-Miller Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining Int J Radiat Oncol Biol Phys 2013
4. S. Takeda, K. Nakamura, Y. Taniguchi, and T.T. Paull Ctp1/ctip and the mrn complex collaborate in the initial steps of homologous recombination Mol Cell 28 2007 351 352
5. P. Baumann, and S.C. West Role of the human RAD51 protein in homologous recombination and double-stranded-break repair Trends Biochem Sci 23 1998 247 251
6. N.L. Sharma, B. Groselj, F.C. Hamdy, and A.E. Kiltie The emerging role of histone deacetylase (HDAC) inhibitors in urological cancers BJU Int 111 2013 537 542
7. M.T. Buckley, J. Yoon, and H. Yee The histone deacetylase inhibitor belinostat (pxd101) suppresses bladder cancer cell growth in vitro and in vivo J Transl Med 5 2007 49
8. G.C. Li, X. Zhang, T.J. Pan, Z. Chen, and Z.Q. Ye Histone deacetylase inhibitor trichostatin a inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest Int J Urol 13 2006 581 586
9. B. Groselj, N.L. Sharma, F.C. Hamdy, M. Kerr, and A.E. Kiltie Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair Br J Cancer 108 2013 748 754
10. C. Blattmann, S. Oertel, and V. Ehemann Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition Int J Radiat Oncol Biol Phys 78 2010 237 245
11. Z. Konsoula, H. Cao, A. Velena, and M. Jung Adamantanyl-histone deacetylase inhibitor h6caha exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity Int J Radiat Oncol Biol Phys 79 2011 1541 1548
12. J.H. Lee, M.L. Choy, L. Ngo, S.S. Foster, and P.A. Marks Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair Proc Natl Acad Sci USA 107 2010 14639 14644
13. J. Bentley, C. L'Hote, and F. Platt Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and Ku DNA-binding activities Genes Chromosomes Cancer 48 2009 310 321
14. J. Bentley, C.P. Diggle, P. Harnden, M.A. Knowles, and A.E. Kiltie DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining Nucleic Acids Res 32 2004 5249 5259
15. B. Qiao, M. Kerr, and B. Groselj Imatinib radiosensitizes bladder cancer by targeting homologous recombination Cancer Res 73 2013 1611 1620
16. K. Rothkamm, I. Kruger, L.H. Thompson, and M. Lobrich Pathways of DNA double-strand break repair during the mammalian cell cycle Mol Cell Biol 23 2003 5706 5715
17. R. Deng, J. Tang, and J.G. Ma Pkb/akt promotes dsb repair in cancer cells through upregulating mre11 expression following ionizing radiation Oncogene 30 2011 944 955
18. Y. Matsumoto, T. Miyamoto, and H. Sakamoto Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly DNA Repair (Amst) 10 2011 314 321
19. A. Munshi, J.F. Kurland, and T. Nishikawa Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity Clin Cancer Res 11 2005 4912 4922
20. L. Geng, K.C. Cuneo, A. Fu, T. Tu, P.W. Atadja, and D.E. Hallahan Histone deacetylase (hdac) inhibitor lbh589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer Cancer Res 66 2006 11298 11304
21. M. Lobrich, A. Shibata, and A. Beucher GammaH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization Cell Cycle 9 2010 662 669
22. P.L. Olive Retention of gammah2ax foci as an indication of lethal DNA damage Radiother Oncol 101 2011 18 23
23. C.P. Diggle, J. Bentley, and A.E. Kiltie Development of a rapid, small-scale DNA repair assay for use on clinical samples Nucleic Acids Res 31 2003 e83
24. H. Zhao, K.R. Luoto, A.X. Meng, and R.G. Bristow The receptor tyrosine kinase inhibitor amuvatinib (mp470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination Radiother Oncol 101 2011 59 65
25. S. Pucci, P. Mazzarelli, and C. Rabitti Tumor specific modulation of Ku70/80 DNA binding activity in breast and bladder human tumor biopsies Oncogene 20 2001 739 747
26. F. Giles, T. Fischer, and J. Cortes A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies Clin Cancer Res 12 2006 4628 4635